Company · CIK 0000873303 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Sarepta Therapeutics, Inc. · SRPT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 FForm 4 → | Sep 8, 8:05 pm EDT | Ryan Ho-Yan WongChief Financial Officer | 13,272 | $22.22 | $294,904 | 121,792 | — | |
| Sep 4, 2026 FForm 4 → | Sep 8, 8:03 pm EDT | Ian Michael EstepanChief Operating Officer | 24,799 | $22.22 | $551,034 | 177,184 | — | |
| Sep 4, 2026 FForm 4 → | Sep 8, 8:02 pm EDT | Cristin RothfussEVP, General Counsel | 22,025 | $22.22 | $489,396 | 115,519 | — | |
| Sep 4, 2026 FForm 4 → | Sep 8, 8:01 pm EDT | Louise Rodino-KlapacPresident, R&D and Tech Ops | 21,423 | $22.22 | $476,019 | 203,900 | — | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:05 pm EDT | Michael SeverinoChief Executive Officer, Director | 756,104 | — | — | 756,104 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 AForm 4 → | Jul 29, 8:05 pm EDT | Michael SeverinoChief Executive Officer, Director | 2,224,342 | — | — | 2,224,342 | — |